Patents by Inventor Christopher M. Antapli

Christopher M. Antapli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Activated cannabinoid controlled release compound tablet and method of forming the same
    Patent number: 11596606
    Abstract: An activated cannabinoid controlled release compound tablet and method of forming the same. In one embodiment, the tablet includes a cannabinoid and a hosting compound mixed with the cannabinoid to form a cannabinoid controlled release compound. The tablet may also include a surfactant mixed with the cannabinoid controlled release compound to form an activated cannabinoid controlled release compound.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: March 7, 2023
    Assignee: METTA MEDICAL INC
    Inventors: Christopher R. Emerson, Christopher M. Antapli, Flip Senn
  • Activated Cannabinoid Controlled Release Compound Tablet and Method of Forming The Same
    Publication number: 20200375907
    Abstract: An activated cannabinoid controlled release compound tablet and method of forming the same. In one embodiment, the tablet includes a cannabinoid and a hosting compound mixed with the cannabinoid to form a cannabinoid controlled release compound. The tablet may also include a surfactant mixed with the cannabinoid controlled release compound to form an activated cannabinoid controlled release compound.
    Type: Application
    Filed: May 29, 2020
    Publication date: December 3, 2020
    Applicant: Metta Medical Inc. (dba Level)
    Inventors: Christopher R. Emerson, Christopher M. Antapli, Flip Senn